CRISPR Therapeutics AG Aktie News
55,24 $
0,88 %
Nasdaq,
24. Mai, 22:12 Uhr
tracken
CRISPR Therapeutics AG Aktie News
Positiv
The Motley Fool
●
etwa 15 Stunden alt
CRISPR Therapeutics is in the process of launching its first medicine. It has plenty of cash, no debt, and manageable expenses.
Neutral
GlobeNewsWire
●
4 Tage alt
-Naimish Patel, M.D., appointed to Chief Medical Officer- -Julianne Bruno, M.B.A.
Positiv
InvestorPlace
●
4 Tage alt
With the interest cuts coming up, it's an ideal time to consider loading up on the top biotech stocks. These stocks continue to dazzle with game-changing medical breakthroughs and explosive growth potential.
Positiv
InvestorPlace
●
5 Tage alt
If you have a budget of around $1,000 and you'd like to buy some solid stocks to beat the market, I've got you covered! The stocks in this article total around ~$383 as of writing if you bought one of each.
Positiv
The Motley Fool
●
5 Tage alt
CRISPR Therapeutics is finally at the cusp of profitability. Its pipeline has quite a few promising opportunities beyond the approved therapies.
Positiv
The Motley Fool
●
5 Tage alt
Indexes are extending bull market gains, reaching new records. It's not too late to get in on the action -- history suggests this bull market could have much farther to go.
Neutral
The Motley Fool
●
10 Tage alt
CRISPR develops cutting-edge therapies that could be transformative. The gene-editing specialist has launched its first approved treatment.
Positiv
InvestorPlace
●
11 Tage alt
They say the best time to invest was 20 years ago. And indeed, that's not too long after the early 2000s recession bottomed out.
Kostenlos registrieren
aktien.guide ist das Tool zum einfachen Finden, Analysieren und Beobachten von Aktien. Lerne von erfolgreichen Investoren und triff fundierte Anlageentscheidungen. Wir machen Dich zum selbstbestimmten Investor.
